191 related articles for article (PubMed ID: 28866221)
1. Microstructural effects in drug release by solid and cellular polymeric dosage forms: A comparative study.
Blaesi AH; Saka N
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():715-727. PubMed ID: 28866221
[TBL] [Abstract][Full Text] [Related]
2. On the exfoliating polymeric cellular dosage forms for immediate drug release.
Blaesi AH; Saka N
Eur J Pharm Biopharm; 2016 Jun; 103():210-218. PubMed ID: 27045468
[TBL] [Abstract][Full Text] [Related]
3. Determination of the mechanical properties of solid and cellular polymeric dosage forms by diametral compression.
Blaesi AH; Saka N
Int J Pharm; 2016 Jul; 509(1-2):444-453. PubMed ID: 27178343
[TBL] [Abstract][Full Text] [Related]
4. 3D-micro-patterned fibrous dosage forms for immediate drug release.
Blaesi AH; Saka N
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():218-229. PubMed ID: 29519432
[TBL] [Abstract][Full Text] [Related]
5. The role of excipient molecular weight in drug release by fibrous dosage forms with close packing and high drug loading.
Blaesi AH; Saka N
Int J Pharm; 2021 Sep; 606():120009. PubMed ID: 33246051
[TBL] [Abstract][Full Text] [Related]
6. Melt-processed polymeric cellular dosage forms for immediate drug release.
Blaesi AH; Saka N
J Control Release; 2015 Dec; 220(Pt A):397-405. PubMed ID: 26519856
[TBL] [Abstract][Full Text] [Related]
7. Expandable, dual-excipient fibrous dosage forms for prolonged delivery of sparingly-soluble drugs.
Blaesi AH; Saka N
Int J Pharm; 2022 Mar; 615():120396. PubMed ID: 33716100
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutical implications of excipient variability on drug dissolution from immediate release products.
Zarmpi P; Flanagan T; Meehan E; Mann J; Østergaard J; Fotaki N
Eur J Pharm Biopharm; 2020 Sep; 154():195-209. PubMed ID: 32681966
[TBL] [Abstract][Full Text] [Related]
9. Expandable fibrous dosage forms for prolonged drug delivery.
Blaesi AH; Saka N
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():110144. PubMed ID: 33545806
[TBL] [Abstract][Full Text] [Related]
10. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
11. Fibrous dosage forms by wet 3D-micro-patterning: Process design, manufacture, and drug release rate.
Blaesi AH; Saka N
Eur J Pharm Biopharm; 2018 Sep; 130():345-358. PubMed ID: 29932976
[TBL] [Abstract][Full Text] [Related]
12. Solid-solution fibrous dosage forms for immediate delivery of sparingly-soluble drugs: Part 2. 3D-micro-patterned dosage forms.
Blaesi AH; Saka N
Mater Sci Eng C Mater Biol Appl; 2021 Oct; 129():110211. PubMed ID: 34579874
[TBL] [Abstract][Full Text] [Related]
13. A Review of Disintegration Mechanisms and Measurement Techniques.
Markl D; Zeitler JA
Pharm Res; 2017 May; 34(5):890-917. PubMed ID: 28251425
[TBL] [Abstract][Full Text] [Related]
14. A study of the impact of excipient shielding on initial drug release using UV imaging.
Hiew TN; Alaudin MIB; Chua SM; Heng PWS
Int J Pharm; 2018 Dec; 553(1-2):229-237. PubMed ID: 30339946
[TBL] [Abstract][Full Text] [Related]
15. The sound of tablets during coating erosion, disintegration, deaggregation and dissolution.
O'Mahoney N; Keating JJ; McSweeney S; Hill S; Lawrence S; Fitzpatrick D
Int J Pharm; 2020 Apr; 580():119216. PubMed ID: 32165222
[TBL] [Abstract][Full Text] [Related]
16. Excipient Stability in Oral Solid Dosage Forms: A Review.
Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
[TBL] [Abstract][Full Text] [Related]
17. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
Casas M; Aguilar-de-Leyva Á; Caraballo I
Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
[TBL] [Abstract][Full Text] [Related]
18. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
[TBL] [Abstract][Full Text] [Related]
19. Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs.
da Fonseca Antunes AB; De Geest BG; Vervaet C; Remon JP
Drug Dev Ind Pharm; 2013 May; 39(5):791-8. PubMed ID: 22871141
[TBL] [Abstract][Full Text] [Related]
20. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
Debotton N; Dahan A
Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
